Clinical Trial Update: A Phase II Clinical Study of Surufatinib Combined With Sintilimab in the Treatment of Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

Phase II clinical study evaluating surufatinib in combination with sintilimab for advanced gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma

Drugs mentioned

• Sintilimab (sintilimab)
• Surufatinib (Surufatinib)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Gastric Adenocarcinoma | Phase 2 | Status: UNKNOWN